PubHawk
Pharmacol Res Perspect April 2023 PMID 36811160

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective.

Hayder M Al-Kuraishy, Ali I Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Abdulrahman A Alsayegh, Najlaa Hamed Almohmadi, Hebatallah M Saad, Gaber El-Saber Batiha

Download social card

Mentions

6
Peak: 2 in Feb 2023
across 3 sources since Feb 2023

Extended reach

46,200
potential audience

Total likes

153

Video views

4,299

Mentions per month

Feb 2023 – Jan 2024

Where it's discussed

  • X / Twitter3 posts
  • News2 articles
  • YouTube1 videos

AI synopsis

What people are saying

Examples include comments highlighting the conflicting evidence about statins’ effects on Parkinson's risk, and phrases like 'important update' and 'controversial topic' demonstrate both curiosity and the article's potential influence on health decisions, shaped by a tone of cautious contemplation.

AgreementModerate agreement

Most discussions acknowledge the complexity of the research, with some supporting the nuanced view that statins may have both protective and harmful effects regarding Parkinson's disease.

InterestHigh interest

The topic draws high interest, as indicated by discussions emphasizing the implications for health and medication use, with phrases like 'important update' and 'must consider' signaling engagement.

EngagementModerate engagement

Participants reference the article's findings and debate potential implications, showing thoughtful analysis rather than surface-level reactions.

ImpactModerate impact

While the discussions indicate the research could influence future studies and medical decisions, the overall consensus suggests moderate to high impact rather than definitive conclusions.

Abstract in brief

  • Statins are widely used to lower cholesterol and prevent cardiovascular diseases, especially in elderly people, but their role in Parkinson's disease (PD) is controversial, with some studies suggesting they might protect against PD while others indicate they could increase its risk.
  • Research findings are mixed; some evidence points to statins reducing PD risk by modulating inflammation and cellular pathways, while other data suggest they may promote PD development by decreasing levels of important molecules like CoQ10.
  • Overall, the relationship between statin use and PD is still uncertain, and more detailed studies are needed to determine whether statins are beneficial or harmful in the context of PD.
Read the full abstract

Top posts

Most liked on X and Bluesky
Agingdoc
@agingdoc1 · X

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective https://t.co/ZhMdemsq8f https://t.co/s1bGYNVBqh

Jul 13, 2023 · 18 likes · 41,343 followers View post →
Ingentium Parkinson's Disease
@Ingentium_PD · X

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective. https://t.co/Fy06XitxkZ https://t.co/Rgx7uXVdqo

Feb 23, 2023 · 515 followers View post →

All mentions

Agingdoc
@agingdoc1 · X

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective https://t.co/ZhMdemsq8f https://t.co/s1bGYNVBqh

Jul 13, 2023 · 18 likes · 41,343 followers View post →
Ingentium Parkinson's Disease
@Ingentium_PD · X

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective. https://t.co/Fy06XitxkZ https://t.co/Rgx7uXVdqo

Feb 23, 2023 · 515 followers View post →
ACHS Research
@AchsResearch · X

New NUTRITION Research Available. Click Here to Access Article(s): https://t.co/ftPE6wqLwn

Feb 23, 2023 · 44 followers View post →